Cargando...
Monitoring Toxicity, Impact, and Adherence of Hydroxyurea in Children with Sickle Cell Disease
Hydroxyurea (HU) is underutilized in sickle cell disease (SCD). Patient adherence with taking HU and with required drug monitoring is a provider perceived barrier to HU utilization.(1-4) To determine process issues that may contribute to these barriers we sought to: 1) describe how providers monitor...
Gardado en:
| Main Authors: | , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
2011
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3804029/ https://ncbi.nlm.nih.gov/pubmed/21815183 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ajh.22101 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|